Efficacy and safety of cysteamine-isobionicamide complex in postinflammatory hyperpigmentation: A 16-week, randomized, double-blinded, vehicle-controlled trial
Background: Postinflammatory hyperpigmentation (PIH) is a prevalent acquired hyperpigmentation disorder with significant psychosocial implications. Cysteamine has demonstrated notable efficacy and safety in treating hyperpigmentation disorders. This study conducted a double-blinded, randomized clini...
Main Authors: | Rosalie Tzu-Li Liu, Tsung-Fu Tsai, Yi-Jing Lai, Chau Yee Ng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.dermsinica.org/article.asp?issn=1027-8117;year=2023;volume=41;issue=4;spage=222;epage=230;aulast=Liu |
Similar Items
-
Topical treatment for postinflammatory hyperpigmentation: a systematic review
by: Marcus G. Tan, et al.
Published: (2022-07-01) -
The role of sunscreen in melasma and postinflammatory hyperpigmentation
by: Sakeena Fatima, et al.
Published: (2020-01-01) -
Postinflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors
by: Alhanouf Bin Dakhil, et al.
Published: (2023-05-01) -
A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: A single-blinded randomized clinical trial
by: Mohammadreza Sobhan, et al.
Published: (2023-01-01) -
Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd: YAG laser: a multicenter survey
by: Hyun Ji Kang, et al.
Published: (2017-07-01)